Document is current

Article History

Received: 15 October 2017

Accepted: 24 April 2018

First Online: 22 May 2018

Ethics approval and consent to participate

: Ethical approval was obtained from St. Vincent’s Hospital, Barwon Health and Deakin University Human Research Ethics Committees. All participants provided written informed consent after receiving a full description of the study.

: Mary Lou Chatterton has received funding support from the NHMRC, Beyond Blue, Barwon Child Youth & Family, and Medibank Private Health Research Fund. She has served as a consultant for Astra Zeneca, Biogen, and Genentech.Cathrine Mihalopoulos was supported by an NHMRC Early Career Development Fellowship (#1035887) at the time of this work. She has also received additional funding support from the NHMRC, Cancer Council, Mental Illness Research Fund, Medibank Private Health Research Fund, Macquarie University, Beyond Blue, Murdoch Children’s Research Institute, The University of Melbourne, The Australian Commonwealth Department of Health and Ageing, and the Australian National Mental Health Commission.Adrienne O’Neil has received funding from Meat and Livestock Australia and is supported by an NHMRC ECR Fellowship (#1052865).Catherine Itsiopoulos has received funding from the NHMRC, the University of Melbourne, Deakin University, La Trobe University, Meat and Livestock Board, Australian Society for Enteral and Parenteral Nutrition, Harokopio University in Athens, Commonwealth Department of Education, Employment and Workplace relations, Diabetes Australia and SWISSE Wellness P/L. She has received speaker honoraria from Astra Zeneca, Boehringer Ingelheim and Dairy Australia.David Castle has received grant monies for research from Eli Lilly, Janssen Cilag, Roche, Allergen, Bristol-Myers Squibb, Pfizer, Lundbeck, Astra Zeneca and Hospira and travel support and honoraria for talks and consultancy from Eli Lilly, Bristol-Myers Squibb, Astra Zeneca, Lundbeck, Janssen Cilag, Pfizer, Organon, Sanofi-Aventis, Wyeth, Hospira and Servier. He is a current Advisory Board Member for Lu AA21004; Lundbeck; Varenicline: Pfizer; Asenapine: Lundbeck; Aripiprazole LAI: Lundbeck; Lisdexamfetamine: Shire; Lurasidone: Servier. He has no stocks or shares in any pharmaceutical company.Michael Berk has received Grant/Research Support from the NIH, Cooperative Research Centre, Simons Autism Foundation, Cancer Council of Victoria, Stanley Medical Research Foundation, MBF, NHMRC, Beyond Blue, Rotary Health, Geelong Medical Research Foundation, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Meat and Livestock Board, Organon, Novartis, Mayne Pharma, Servier and Woolworths. He has been a speaker for Astra Zeneca, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Janssen Cilag, Lundbeck, Merck, Pfizer, Sanofi Synthelabo, Servier, Solvay and Wyeth, and served as a consultant to Allergan, Astra Zeneca, Bioadvantex, Bionomics, Collaborative Medicinal Development, Eli Lilly, Glaxo SmithKline, Janssen Cilag, Lundbeck Merck, Pfizer and Servier. He is supported by an NHMRC Senior Principal Research Fellowship (#1059660).Felice N Jacka has received Grant/Research support from the Brain and Behaviour Research Institute, the NHMRC, Australian Rotary Health, the Geelong Medical Research Foundation, the Ian Potter Foundation, Eli Lilly, Meat and Livestock Australia, Woolworths Limited and The University of Melbourne and has received speakers honoraria from Sanofi-Synthelabo, Janssen Cilag, Servier, Pfizer, Health Ed, Network Nutrition, Angelini Farmaceutica, Metagenics and Eli Lilly. She is supported by an NHMRC Career Development Fellowship (#1108125).The other authors have no relevant financial disclosures to declare.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.